Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Invest NowTata India Pharma & Healthcare Fund-Regular Plan-Growth
Invest NowChart Comparison
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹2760 Cr | ₹949 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 14 Jul 1999 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 32% | 26.49% |
Expense Ratio | 2 | 2.21 |
Manager | Pradeep Kesavan | Meeta Shetty |
ISIN Code | INF200K01446 | INF277K016A9 |
Exits Load | Exit load of 0.50% if redeemed within 15 days/365 | Exit load of 0.25% if redeemed within 30 days./365 |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 5.72% | 7.23% |
6 Month | 15.48% | 21.76% |
1 Year | 45.23% | 52.93% |
3 Year | 20.72% | 19.75% |
5 Year | 29.9% | 28.8% |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | - | - |
1 Year | 15.2% | 17.22% |
3 Year | 44.51% | 42.6% |
5 Year | 82.64% | 77.31% |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 14.55% | 6.62% |
3 Year | 17.1% | 17.45% |
5 Year | 12.47% | 14.18% |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 14.02% | 14.23% |
Sharp | 0.78% | 0.74% |
Beta | 0.87% | 0.9% |
Alpha | 3.06% | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts GuidanceScheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Pradeep Kesavan | Meeta Shetty |
Total AUM | ₹434274 Cr | ₹17847 Cr |
Fund Manage | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 8.64 | 5.34 |
Mid Cap | 29.49 | 39.68 |
Small Cap | 27.81 | 16.33 |
Large Cap | 34.06 | 38.65 |
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 3.46 | 3.05 |
Healthcare | 92.23 | 93.35 |
Chemicals | 4.31 | 1.31 |
Services | - | 2.29 |
Top Comparisons
SBI Long Duration Fund - Regular Plan - Growth
3Y Returns0%
SBI Long Duration Fund - Regular Plan - Growth
3Y Returns0%
Kotak Flexicap Fund - Growth
3Y Returns14.4%
Mirae Asset Flexi Cap Fund - Regular Plan - Growth
3Y Returns0%
Invesco India Medium Duration Fund - Regular - Growth
3Y Returns4.74%
Aditya Birla Sun Life Medium Term Plan - Growth - Regular Plan
3Y Returns12.77%
UTI Liquid Fund - Regular Plan - Growth Option
3Y Returns6.21%
Quant Liquid Fund-Growth
3Y Returns5.79%